Related Experiment Video
Updated: May 31, 2026

Vascular Balloon Injury and Intraluminal Administration in Rat Carotid Artery
Published on: December 23, 2014
Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4
Hae Jin Kee1, Jin-Sook Kwon, Sera Shin
1Department of Pharmacology and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea. sshjkee@empas.com
Abstract:
The proliferation of vascular smooth muscle cells (VSMCs) is an integral part of the mechanism of vascular diseases such as restenosis. Post-translational modifications by histone deacetylase (HDAC) inhibitors play an important role in the regulation of gene expression by inducing cell cycle arrest. However, the role and mechanism of the HDAC inhibitor trichostatin A (TSA) on neointimal proliferation remain unknown. In this study, we investigated the effect and mechanism whereby TSA prevents the proliferation of VSMCs and neointimal hyperplasia induced by balloon injury in rat carotid artery. Local administration of TSA significantly prevented neointimal hyperplasia. TSA dramatically inhibited the proliferation and DNA synthesis of VSMCs in response to FBS or PDGF-BB. Overexpression of Krüppel like factor 4 (KLF4) blocked the cell proliferation and DNA synthesis, as determined by the MTT and [³H]thymidine incorporation assays, whereas knockdown of KLF4 resulted in an increase in VSMC proliferation. In VSMCs, TSA increased the mRNA level and protein expression of KLF4. Treatment with TSA or transfection of KLF4 increased the expression of both p21 and p27 and promoter activity. In addition, the anti-proliferative activity of TSA was recovered in KLF4-knockdown cells. These data demonstrate that TSA inhibits neointimal thickening and VSMC proliferation via activation of the KLF4/p21/p27 signaling pathway.
Insights
Trichostatin A (TSA) prevents vascular smooth muscle cell (VSMC) proliferation and neointimal hyperplasia by activating the Krüppel like factor 4 (KLF4)/p21/p27 pathway. This finding offers a potential therapeutic strategy for vascular diseases like restenosis.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Pharmacology
Background:
- Vascular smooth muscle cell (VSMC) proliferation is central to vascular diseases such as restenosis.
- Histone deacetylase (HDAC) inhibitors regulate gene expression and cell cycle arrest, but the specific role of trichostatin A (TSA) in neointimal proliferation is unclear.
Purpose of the Study:
- To investigate the effect and mechanism of TSA in preventing VSMC proliferation and neointimal hyperplasia.
- To elucidate the role of Krüppel like factor 4 (KLF4) in TSA-mediated inhibition of VSMC proliferation.
Main Methods:
- Balloon injury model in rat carotid artery with local TSA administration.
- In vitro VSMC proliferation assays (MTT, [³H]thymidine incorporation) with TSA, FBS, PDGF-BB.
- KLF4 overexpression and knockdown experiments.
- Analysis of KLF4, p21, and p27 mRNA and protein expression, and promoter activity.
Main Results:
- Local TSA administration significantly reduced neointimal hyperplasia in vivo.
- TSA inhibited VSMC proliferation and DNA synthesis in response to growth factors.
- KLF4 overexpression suppressed VSMC proliferation, while KLF4 knockdown increased it.
- TSA treatment increased KLF4 expression, which in turn upregulated p21 and p27 expression and promoter activity.
- The anti-proliferative effect of TSA was dependent on KLF4.
Conclusions:
- TSA effectively inhibits neointimal thickening and VSMC proliferation.
- TSA exerts its anti-proliferative effects through the KLF4/p21/p27 signaling pathway.
- This pathway represents a potential therapeutic target for managing vascular proliferative diseases.
Related Concept Videos
The JAK-STAT Signaling Pathway
Inhibition of Cdk Activity
Regulation of Angiogenesis and Blood Supply
Intracellular Signaling Affects Focal Adhesions
Some...
PI3K/mTOR/AKT Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

